Abstract: A user wearable urinal bag concealment device for discrete public urination includes a first panel and a second panel. The second panel has a lower edge and opposing side edges that are coupled to a front face of the first panel to define a pouch that accessible at an upper edge of the second panel. A plurality of couplers that is coupled to an upper limit of the first panel is configured to couple the first panel to a male user so that the first panel is positioned over and substantially conceals a groin area of the male user. A slot is positioned in the first panel. The pouch is configured to position a urinal bag and to insert hands of the user, positioning the user to manipulate his penis through the slot into an open end of the urinal bag to discretely collect his urine.

Abstract: A wearable band transdermal medication device including one or more chamber for dispensing liquid transdermal medication, a device housing, and a transdermal applicator for the transdermal medication. The chamber includes a pouch containing a liquid transdermal medication pressurized at a first pressure, and an outlet for selective dispensing of the medication to a delivery section of the transdermal medication delivery device. The outlet may be a self-sealing membrane that dispenses liquid medication when subjected to a negative pressure differential, or may be a magnetic valve assembly. The device is configured as wristband, armband or other band worn by the patient with the transdermal applicator at an outer face of the device housing in contact with the patient's skin. A plurality of chambers housed by the device operate under electrical control to dispense medication, subject to access authorization, and subject to regimens for transdermal administration of the liquid medication.

Abstract: A hand-held dispenser to dispense fluid includes a casing to fit into a hand of a user, a nozzle in the casing to dispense a mist, a fluid reservoir contained in the casing to hold a fluid to be turned into the mist, a filament extension atomizer contained in the casing to generate the mist, an air source contained in the casing to provide air flow to direct the mist to the nozzle, a motor contained in the casing to operate the filament extension atomizer, an actuator positioned on the casing to activate the dispenser, a control circuit contained in the casing to receive a signal from the actuator and to send a signal to the motor to cause the motor to actuate, and a power source contained in the casing to provide power to the motor upon receive a signal from the control circuit.

Abstract: A clip retains tapered connector members which joining tubing sections of a medical fluid drainage system, such as a urinary collection system. The clip has first and second ends configured to bear against external flanges projecting from the tapered connector members. A central body of the clip applies a controllable compression force to the first and second ends for urging the connector members together. The first and second ends include sub-fingers for snapping onto a respective one of the tapered connector members.

Abstract: A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.

Abstract: A balloon catheter having an elongated catheter shaft defining a fluid drainage lumen and a balloon inflation lumen. The balloon catheter includes a fluid drainage port disposed about the distal end of the catheter shaft in fluid communication with the fluid drainage lumen, and a balloon inflation port disposed about the distal end of the catheter shaft in fluid communication with the balloon inflation lumen. A balloon portion is disposed about the distal end of the catheter shaft in fluid communication with the balloon inflation port. A release device is disposed in fluid communication with the balloon portion and the fluid drainage lumen, and includes an activating member. A tether is attached to the activating member of the release device. Tension applied to the tether activates the release device, enabling fluid flow from the balloon portion into the fluid drainage lumen and out of the body.

Abstract: Embodiments are disclosed of a method of controlling timing and/or dosage of a transdermal drug patch. For example, a control device operative to move the patch to one or more of a plurality of operational relationships with a skin of a patient, including being fully engaged with the skin, partially engaged with the skin, and disengaged with the skin. The device may include a roller that peels a patch on and off the skin. Optionally a convention patch is used. In some embodiments a patch and/or an adaptor has a mobile zone and an immobile zone. In some embodiments, an active surface of the patch fully contacts the skin in an engaged state. For example the patch may be attached to the device on a passive portion thereof.

Abstract: An implantable prosthesis is provided for repairing a fistula, such as an anal fistula. The prosthesis or fistula repair device may include a body with a shape configured for placement in the fistula. The prosthesis may also include an anchor or base that is located at one or both ends of the body to facilitate anchoring the prosthesis in position. The prosthesis may include one or more channels to create one or more pathways for drainage and/or irrigation of the fistula. The channel may have a relatively uniform dimension along its length or a tapered shape that increases along its length. The prosthesis may have an adjustable length for accommodating fistula tracts of varying lengths. The prosthesis may include elongated body segments that provide a wicking or capillary function to facilitate drainage of the fistula tract.

Abstract: A drip chamber is provided that includes a hollow body and a nucleation column extending into the interior of the hollow body. The nucleation column can be formed with, or treated by a treatment to include, microfeatures or other surface properties that provide nucleation sites for the nucleation and amalgamation of microbubbles. The drip chamber can include a bubble catcher in the bottom of the hollow body and the nucleation column can extend from the bubble catcher into the interior of the hollow body. Methods of making such drip chambers are also provided.

Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.

Abstract: A chest drainage system, including a circulation assembly having an intake for taking fluid into the system and an exhaust for exhausting fluid out of the system. An intake flow device is configured to selectively control fluid flow through the intake and an exhaust flow device is configured to selectively controlling fluid flow through the exhaust. The circulation assembly has a first configuration and a second configuration such that transitioning between the first and second configurations during operation of the circulation assembly displaces at least a portion of fluid within the system with fluid from outside the system via the intake and the exhaust. A sensor is arranged in fluid communication with the fluid within the system and configured to detect a concentration of a reference fluid in the fluid in the system.

Abstract: A fecal collection device includes a barrel with a waste drain conduit attached thereto. A drain opening is defined between passages of the barrel and the waste drain conduit. An irrigation conduit is connected to a source of lavage liquid. A trocar plug has a tapered distal end and moves between insertion, irrigation and flushing positions within the barrel passage. When in the insertion position, the tapered distal end of the trocar plug extends from the distal end of the barrel. When in the irrigation position, the irrigation conduit may provide lavage liquid to the barrel passage while the trocar plug covers a majority of the drain opening. When in a flushing position, the trocar plug covers less of the drain opening than when the trocar plug is in the irrigation position.

Abstract: A control system in a blood line (12) of a cardiopulmonary bypass perfusion system (1) comprises a flow sensor (26) to determine a flow value indicative of the flow rate, a controller configured to process the flow value, and an adjustable restriction (28) responsive to the controller, to reduce the flow rate in the venous blood line (12) to maintain a flow rate to the venous blood reservoir that does not exceed a restriction threshold. As the adjustable restriction (28) is responsive to the flow sensor (26), this provides a closed loop control mechanism that avoids restricting the blood line (12) of the perfusion system (1) more than intended.

Abstract: An implant device is configured to be implanted in a fistula to fluidly connect the lacrimal apparatus and a paranasal sinus. A surgical tool has an implant the implant device mounted on a carrier. Various methods involve a fistula between the lacrimal apparatus and a paranasal sinus. A kit includes an entry device for use to form a fistula and an implant tool for use to implant an implant device following formation of a fistula.

Abstract: An ostomy appliance includes a first adhesive having a first surface and a second surface opposing the first surface. The first surface is provided to contact a partly electrically conductive object. The appliance also includes a first layer situated on the second surface of the first adhesive, and a first electrode situated on the first layer and electrically isolated from the first adhesive.

Abstract: Systems, methods, and dressing are presented for treating a tunnel wound on a patient. In one instance, a reduced-pressure, tunnel-wound dressing includes a longitudinal core member formed from a closed-cell foam that is surrounded by a first longitudinal concentric member formed from a manifolding material. When subjected to reduced pressure, the longitudinal core member expands and the first longitudinal concentric member compresses. These actions create intimate contact between the tunnel wound and the dressing, oppose collapse of the tunnel, and when reduced pressure is removed provide clearance to remove the dressing. Other embodiments are presented.

Abstract: A medical/surgical lavage unit including internal ribs that extend into a void space of a suction tube attached to the lavage unit.

Abstract: A chemical pump assembly useful for negative pressure therapy includes a chemical pump housing having an inner chamber, a reactor located within the inner chamber, an opening provided in the chemical pump housing, a first pull tab which extends from the inner chamber to ambient through the opening, and a removable layer connected to the first pull tab. The reactor is configured to react with a selected gas found in air so as to consume the selected gas when exposed to air in the inner chamber. The removable layer shields the reactor from air in the inner chamber atmosphere until the removable layer is removed.

Abstract: A device (1) for the application of liquid medical substances (100) comprises a main body (2) extending around a longitudinal axis (X) and comprising a housing portion (3) at a first open end (4) and a delivery portion (5) at a second open end (6) which is opposite the first (4); a hermetically sealed cartridge reservoir (7) containing a liquid medical substance (100); a perforating element (8) disposed inside the main body (2) in a position falling between the housing portion (3) and the delivery portion (5) and such as to achieve the perforation of one end of the cartridge reservoir (7). The perforating element (8) has a tubular shape and comprises, in a central portion thereof, a cylindrical conduit (12) having a cutting edge (14) faced towards the housing portion (3).

Abstract: Fluid is drained from a bleb using a device including a tubular member having opposed open ends to enable the fluid to flow from end to end through the tubular member. Inward from one end is a stop element enabling the one end to be inserted in one direction through a wall of the bleb but preventing the inserted end from being pulled in the opposite direction through the bleb wall. The opposed remote end of the tubular member is inserted into the retrobulbar space to enable fluid exiting the tubular member at this remote end to drain into the tissue. Along an exterior of the tubular member is an anchoring element enabling the device to be sutured in position. An ophthalmic product has a bleb drainage feature.